CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D)....
The joint drug discovery project announced yesterday will combine Centogene’s genetic testing service offerings with Evotec's iPSC platform and drug discovery capabilities.
A device that isolates and sprays a patient’s own stem cells onto serious burns could have significant implications in the organ regeneration industry, says developer RenovaCare.
Researchers supported by the National Institutes of Health (NIH) have developed a clinical-grade stem cell line, which will help accelerate early-stage clinical research.
Stemedica Cell Technologies’ new license to make stem cells for trials positions the firm as a “valuable resource for front line researchers,” according to VP of business development Dave McGuigan.
The US Food and Drug Administration (FDA) gave the go-ahead to the first clinical trials of a stem cell-based therapy late last week, in a major boost to the development of the technology.
UK researchers have developed two synthetic molecules that coax stem cells to differentiate into either neurons or epithelial cells for use in drug discovery applications.
Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.
Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.
Researchers have genetically engineered normal skin cells into
cancer stem cells - a previously elusive type of stem cell that are
thought to drive cancer.
Scientists believe they may have found the key to eliminating stem
cells that pose a cancerous threat when it comes to differentiation
during the cell's life cycle.
It had been touted as providing a less controversial alternative to
embryonic stem cells, but Italian researchers have thrown into
question the validity of research claiming to demonstrate the use
of amniotic stem cells to generate...
A startling breakthrough has allowed scientists to create human
stem cells from just reprogrammed skin cells, with no embryo and
thus, perhaps no ethical dilemma.
US researchers have developed a way of creating primate embryonic
stem cells that avoids the need to use fertilised embryos,
potentially leading to more ethical ways of curing degenerative
diseases.
US researchers have developed a fully automated microfluidic cell
culture system that can control signalling agents in the
extracellular media while maintaining cell viability for weeks.
Three of the world's biggest pharmaceutical companies have signed a
landmark deal with the UK government that will see them use stem
cell technology to road-test the safety of new compounds.
The launch of Invitrogen's Stempro EZPassage should substantially
reduce the time and stress involved in dividing up cultures of
human embryonic stem cell (hESC) colonies.
Medicult, a Danish company best known for supplying products for
use in fertility clinics, has developed a protein-free cell culture
medium that could cut out problems associated with current media.
A team of Canadian scientists have identified which genes help
decide a stem cell's fate; a discovery that one day could lead to
drugs that invoke their regenerative power.
Specific stem cells are thought to be the origin of many, if not
all, cancers and although there are several drugs in clinical
trials, only small companies are currently conducting research in
the area.
A new study has shown that certain human bone marrow stem cells can differentiate into sperm stem cells - potentially leading to a revolution in fertility therapy.
Not only can stem cells replace diseased brain tissue, but they can
also form functional nerve cells that transmit electrical impulses,
according to scientists working on rare brain disorders.
Cellartis has begun a new research programme in Scotland as part of
a £9.5m (€14.5m) programme by ITI Life Sciences to develop the
world's first automated process to produce high-quality human stem
cells.
Researchers at the University of Rochester and StemCapture have
unveiled a new device technology that makes it possible to harvest
stem cells from the blood, bypassing the controversial use of stem
cells sourced from embryos.
Scientists have discovered stem cells in the amniotic fluid that
surrounds the foetus in pregnant women, bypassing ethical concerns
over the source of the versatile cells.
According to a new report, worldwide revenues for cell and cytokine
therapies in regenerative medicine are set to reach $20.7 billion
(€17.3 billion) in 2010 in a sector that provides a viable
alternative to using drugs or other therapies.
Stem cells have the potential to become an effective diagnostic
tool singling out those susceptible of atherosclerosis, say
researchers. These cells could also help to predict regeneration of
heart cells following a heart attack.
Scientists in the UK are tipped to be given approval this week to
create cloned human embryos to harvest stem cells to treat diabetes
patients and with the possibility of treating other diseases such
as Parkinson's and Alzheimer's.
Scientists in South Korea have isolated stem cells from a cloned
human embryo for the first time, bringing the use of cell- or
tissuse-based therapies for treating disease a step nearer. But the
work has also re-ignited the controversy...
